261 related articles for article (PubMed ID: 8805515)
1. The complex of the anti-cancer therapeutic, BW1843U89, with thymidylate synthase at 2.0 A resolution: implications for a new mode of inhibition.
Stout TJ; Stroud RM
Structure; 1996 Jan; 4(1):67-77. PubMed ID: 8805515
[TBL] [Abstract][Full Text] [Related]
2. Binding of the anticancer drug ZD1694 to E. coli thymidylate synthase: assessing specificity and affinity.
Rutenber EE; Stroud RM
Structure; 1996 Nov; 4(11):1317-24. PubMed ID: 8939755
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of a deletion mutant of human thymidylate synthase Delta (7-29) and its ternary complex with Tomudex and dUMP.
Almog R; Waddling CA; Maley F; Maley GF; Van Roey P
Protein Sci; 2001 May; 10(5):988-96. PubMed ID: 11316879
[TBL] [Abstract][Full Text] [Related]
4. Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed, an antifolate drug.
Phan J; Koli S; Minor W; Dunlap RB; Berger SH; Lebioda L
Biochemistry; 2001 Feb; 40(7):1897-902. PubMed ID: 11329255
[TBL] [Abstract][Full Text] [Related]
5. Folate-based thymidylate synthase inhibitors as anticancer drugs.
Jackman AL; Calvert AH
Ann Oncol; 1995 Nov; 6(9):871-81. PubMed ID: 8624289
[TBL] [Abstract][Full Text] [Related]
6. The role of protein dynamics in thymidylate synthase catalysis: variants of conserved 2'-deoxyuridine 5'-monophosphate (dUMP)-binding Tyr-261.
Newby Z; Lee TT; Morse RJ; Liu Y; Liu L; Venkatraman P; Santi DV; Finer-Moore JS; Stroud RM
Biochemistry; 2006 Jun; 45(24):7415-28. PubMed ID: 16768437
[TBL] [Abstract][Full Text] [Related]
7. Kinetic scheme for thymidylate synthase from Escherichia coli: determination from measurements of ligand binding, primary and secondary isotope effects, and pre-steady-state catalysis.
Spencer HT; Villafranca JE; Appleman JR
Biochemistry; 1997 Apr; 36(14):4212-22. PubMed ID: 9100016
[TBL] [Abstract][Full Text] [Related]
8. The structural mechanism for half-the-sites reactivity in an enzyme, thymidylate synthase, involves a relay of changes between subunits.
Anderson AC; O'Neil RH; DeLano WL; Stroud RM
Biochemistry; 1999 Oct; 38(42):13829-36. PubMed ID: 10529228
[TBL] [Abstract][Full Text] [Related]
9. The crystal structure of thymidylate synthase from Pneumocystis carinii reveals a fungal insert important for drug design.
Anderson AC; Perry KM; Freymann DM; Stroud RM
J Mol Biol; 2000 Mar; 297(3):645-57. PubMed ID: 10731418
[TBL] [Abstract][Full Text] [Related]
10. Crystal structures of thymidylate synthase mutant R166Q: structural basis for the nearly complete loss of catalytic activity.
Sotelo-Mundo RR; Changchien L; Maley F; Montfort WR
J Biochem Mol Toxicol; 2006; 20(2):88-92. PubMed ID: 16615077
[TBL] [Abstract][Full Text] [Related]
11. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
[TBL] [Abstract][Full Text] [Related]
12. Crystal structures of a marginally active thymidylate synthase mutant, Arg 126-->Glu.
Strop P; Changchien L; Maley F; Montfort WR
Protein Sci; 1997 Dec; 6(12):2504-11. PubMed ID: 9416600
[TBL] [Abstract][Full Text] [Related]
13. Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate.
Montfort WR; Perry KM; Fauman EB; Finer-Moore JS; Maley GF; Hardy L; Maley F; Stroud RM
Biochemistry; 1990 Jul; 29(30):6964-77. PubMed ID: 2223754
[TBL] [Abstract][Full Text] [Related]
14. An essential role for water in an enzyme reaction mechanism: the crystal structure of the thymidylate synthase mutant E58Q.
Sage CR; Rutenber EE; Stout TJ; Stroud RM
Biochemistry; 1996 Dec; 35(50):16270-81. PubMed ID: 8973201
[TBL] [Abstract][Full Text] [Related]
15. Ligand-induced distortion of an active site in thymidylate synthase upon binding anticancer drug 1843U89.
Weichsel A; Montfort WR
Nat Struct Biol; 1995 Dec; 2(12):1095-101. PubMed ID: 8846221
[TBL] [Abstract][Full Text] [Related]
16. Biochemical effects of folate-based inhibitors of thymidylate synthase in MGH-U1 cells.
Mitrovski B; Pressacco J; Mandelbaum S; Erlichman C
Cancer Chemother Pharmacol; 1994; 35(2):109-14. PubMed ID: 7987985
[TBL] [Abstract][Full Text] [Related]
17. Comparative cytotoxicity of folate-based inhibitors of thymidylate synthase and 5-fluorouracil +/- leucovorin in MGH-U1 cells.
Erlichman C; Mitrovski B
Cancer Chemother Pharmacol; 1994; 34(1):51-6. PubMed ID: 8174202
[TBL] [Abstract][Full Text] [Related]
18. Role of an invariant lysine residue in folate binding on Escherichia coli thymidylate synthase: calorimetric and crystallographic analysis of the K48Q mutant.
Arvizu-Flores AA; Sugich-Miranda R; Arreola R; Garcia-Orozco KD; Velazquez-Contreras EF; Montfort WR; Maley F; Sotelo-Mundo RR
Int J Biochem Cell Biol; 2008; 40(10):2206-17. PubMed ID: 18403248
[TBL] [Abstract][Full Text] [Related]
19. Role of the conserved tryptophan 82 of Lactobacillus casei thymidylate synthase.
Kealey JT; Eckstein J; Santi DV
Chem Biol; 1995 Sep; 2(9):609-14. PubMed ID: 9383465
[TBL] [Abstract][Full Text] [Related]
20. Phosphorus-31 nuclear magnetic resonance studies of complexes of thymidylate synthase.
Connick TJ; Reilly RT; Dunlap RB; Ellis PD
Biochim Biophys Acta; 1994 Sep; 1208(1):118-26. PubMed ID: 8086425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
